Literature DB >> 11850830

Endonuclein is a cell cycle regulated WD-repeat protein that is up-regulated in adenocarcinoma of the pancreas.

Bent Honoré1, Ulrik Baandrup, Søren Nielsen, Henrik Vorum.   

Abstract

The transcript encoding endonuclein, the human homolog of yeast PWP1, was previously found up-regulated in pancreatic cancer tissue. By immunohistochemistry we detected a ubiquitous presence in several tissues examined: skin, liver, thyroid gland, heart muscle, neurons, kidney, bladder, pancreas, adrenal gland, ovary, uterus, testis and prostate gland. We especially noticed that normal pancreatic exocrine cells exhibited low protein levels while pancreatic adenocarcinoma cells revealed high levels. We found a heterogeneous subcellular distribution, especially with varying nuclear levels. In proliferating cells endonuclein protein expression and localization was cell cycle dependent, with increasing levels and nuclear focusing during the interphase toward mitosis. Ultrastructural analysis revealed ER and nuclear localization. Endonuclein contains five WD-repeats, indicating a putative role in crucial regulatory activities in the nucleus as well as in the ER.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850830     DOI: 10.1038/sj.onc.1205186

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation.

Authors:  Fabio Pittella Silva; Ryuji Hamamoto; Yusuke Nakamura; Yoichi Furukawa
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity.

Authors:  Maja Ludvigsen; Morten Østergaard; Henrik Vorum; Christian Jacobsen; Bent Honoré
Journal:  BMC Biochem       Date:  2009-12-22       Impact factor: 4.059

Review 3.  WD40 Repeat Proteins: Signalling Scaffold with Diverse Functions.

Authors:  Buddhi Prakash Jain; Shweta Pandey
Journal:  Protein J       Date:  2018-10       Impact factor: 2.371

4.  HNRNPH1 is required for rhabdomyosarcoma cell growth and survival.

Authors:  Yanfeng Li; Jesse Bakke; David Finkelstein; Hu Zeng; Jing Wu; Taosheng Chen
Journal:  Oncogenesis       Date:  2018-01-24       Impact factor: 7.485

5.  no child left behind encodes a novel chromatin factor required for germline stem cell maintenance in males but not females.

Authors:  Abbie L Casper; Kelly Baxter; Mark Van Doren
Journal:  Development       Date:  2011-07-13       Impact factor: 6.868

6.  PWP1 Promotes the Malignant Phenotypes of Lung Cancer Cells by Interacting with DVL2 and Merlin.

Authors:  Lai Wei; Pengcheng Li; Yuan Luo; Meiyu Zhang; Ting Yan; Yue Yang; Yuchen Han; Shuli Liu; Enhua Wang
Journal:  Onco Targets Ther       Date:  2020-10-08       Impact factor: 4.147

7.  Lack of Wdr13 gene in mice leads to enhanced pancreatic beta cell proliferation, hyperinsulinemia and mild obesity.

Authors:  Vijay Pratap Singh; B Jyothi Lakshmi; Shalu Singh; Vanya Shah; Sandeep Goel; D Partha Sarathi; Satish Kumar
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

8.  The functional landscape of mouse gene expression.

Authors:  Wen Zhang; Quaid D Morris; Richard Chang; Ofer Shai; Malina A Bakowski; Nicholas Mitsakakis; Naveed Mohammad; Mark D Robinson; Ralph Zirngibl; Eszter Somogyi; Nancy Laurin; Eftekhar Eftekharpour; Eric Sat; Jörg Grigull; Qun Pan; Wen-Tao Peng; Nevan Krogan; Jack Greenblatt; Michael Fehlings; Derek van der Kooy; Jane Aubin; Benoit G Bruneau; Janet Rossant; Benjamin J Blencowe; Brendan J Frey; Timothy R Hughes
Journal:  J Biol       Date:  2004-12-06

9.  Overexpression of WDR79 in non-small cell lung cancer is linked to tumour progression.

Authors:  Yang Sun; Chao Yang; Jieying Chen; Xin Song; Zhen Li; Minlan Duan; Jianglin Li; Xiaoxiao Hu; Kuangpei Wu; Guobei Yan; Cai Yang; Jing Liu; Weihong Tan; Mao Ye
Journal:  J Cell Mol Med       Date:  2016-02-05       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.